Chromatin remodeling regulates gene expression in response to the accumulation of misfolded polyQ proteins associated with Huntington's disease (HD). Tra1 is an essential component of both the SAGA/SLIK and NuA4 transcription co-activator complexes and is linked to multiple cellular processes, including protein trafficking and signaling pathways associated with misfolded protein stress. Cells with compromised Tra1 activity display phenotypes distinct from deletions encoding components of the SAGA and NuA4 complexes, indicating a potentially unique regulatory role of Tra1 in the cellular response to protein misfolding.
| INTRODUCTION
Eukaryotic cells need to correctly fold proteins to ensure their accurate function and avoid the aggregation of toxic misfolded intermediates, which form the basis of several human diseases. [1] [2] [3] [4] In
Huntington's disease (HD), expansion of a polyglutamine region encoded by the first exon of the gene encoding the Huntingtin protein (Htt ex1 ) leads to Htt misfolding and aggregation in detergent-insoluble, amyloid-like inclusion bodies (IBs) in the cytoplasm and nuclei of neuronal cells. [5] [6] [7] Accumulation of toxic polyQ oligomers is linked to several cellular dysfunctions such as defects in protein trafficking, autophagy and endoplasmic reticulum stress. [8] [9] [10] [11] [12] [13] [14] In response to the accumulation of misfolded proteins, including polyQ huntingtin, cells modify their gene expression profile to favor adaptive responses directed at restoring protein homeostasis. [15] [16] [17] Well-characterized responses to proteotoxic stress, such as the unfolded protein response of the endoplasmic reticulum 11, 13, 14, [18] [19] [20] [21] and the heat shock response [22] [23] [24] [25] in the cytoplasm, increase the folding capacity of their respective compartments upon accumulation of misfolded polyQ expansions. These responses prevent the protein quality control machinery from being overwhelmed by sudden changes in the misfolded protein burden.
It is now clear that multiple signaling pathways act in parallel to regulate gene expression during misfolded protein stress. Acetyltransferase complexes regulate chromatin remodeling, a process affected in HD. [26] [27] [28] [29] [30] [31] The SAGA (Spt-Ada-Gcn5-Acetyltransferase) and NuA4
(Nucleosome Acetyltransferase of H4) complexes were first identified in yeast as containing the lysine acetyltransferases Gcn5 and Esa1, respectively. [32] [33] [34] Both complexes have homologues in mammalian cells, hSAGA and Tip60, respectively. The PIKK family member Tra1/TRRAP is an essential component of both SAGA and NuA4 complexes in yeast and mammalian cells. 35, 36 The group of PIKK proteins also includes mTOR, ATM and ATR, which are characterized by a C-terminal PI3K domain. 37 In SAGA and NuA4, Tra1 interacts with transcriptional activators thereby recruiting the complexes to target promoters. [38] [39] [40] [41] Because of its presence in both SAGA and NuA4, reducing Tra1 function affects cells distinctly from deletions of components specific to either individual complex. For example, impaired Tra1 function causes generationdependent telomere shortening, a phenotype that is not detected in cells carrying deletions of either SAGA or NuA4 components. 42 Misfolded polyQ expansions specifically alter the composition of the SAGA complex and SAGA-regulated gene transcription in both yeast and mammalian models. [43] [44] [45] [46] [47] [48] These studies employed polyQ-expanded ataxin-7/Sca7, which causes the neurodegenerative disease spinocerebellar ataxia 7. 49 Sca7/ataxin-7 is a component of SAGA and SLIK (SAGA-like) acetyltransferase complexes, explaining the effect of polyQ-expanded Sca7 on SAGA function. 43 , 44 Targeting Htt ex1 to the yeast nucleus also alters transcription similarly to cells carrying deletions in genes encoding SAGA components 50 ; however, the specific molecular mechanism by which Htt ex1 polyQ expansions affect SAGA function remains unclear.
Our previous genetic screen for synthetic interactions linked Tra1 to the regulation of several stress responses, including protein misfolding stress. 51 Tra1 is therefore a strong candidate target to regulate the transcriptional response to protein misfolding stress caused by polyQ proteins.
To study the effect of Htt ex1 polyQ expansion on yeast, we employed a well-characterized model that involves expressing fluorescently tagged Htt ex1 . [52] [53] [54] [55] [56] [57] We define the interplay between Tra1-and polyQ-induced stress and identify the TORC1 effector Sfp1 as a regulator of polyQ toxicity that regulates Tra1 expression during proteotoxic stress. Our study thus expands the understanding of its role beyond the regulation of cell growth and ribosome biogenesis [58] [59] [60] and defines how TORC1, Sfp1 and Tra1 respond to toxic polyQ proteins.
2 | RESULTS
| PolyQ expansions compromise the SAGA acetyltransferase complex
In our experiments, Htt ex1 is placed under the control of the GAL1
promoter and induced by growth in galactose as a sole carbon source.
Under these conditions, expressing HD-associated polyQ lengths 46Q
and 72Q result in a polyQ length-dependent growth defect compared to the non-HD-associated 25Q 14, 54, 55 ( Figure 1A ). 25Q does not cause a growth defect when compared to the corresponding empty vector (Supporting Information Figure S1 ). As opposed to other disease-causing misfolded proteins, such as α-synuclein, polyQ expression inhibits cell growth but does not cause significant cell death as measured by either regrowth assays or labeling of dead cells with propidium iodide ( Figure S2 ). The effect of a 103Q Htt ex1 polyQ expansion is also apparent when expressed at lower levels under the transcriptional control of the relatively weak MET25 promoter 14 ( Figure 1B ). This model allows testing low polyQ toxicity without altering the carbon source. High expression of polyQ-expanded Htt ex1 results in polyQ length-dependent formation of cytoplasmic aggregates that can be observed using fluorescent microscopy ( Figure 1C ).
Misfolded polyQ proteins associated with the polyglutamine disease spinocerebellar ataxia disrupt assembly of the SAGA complex and SAGA-dependent transcription. 44 The ensuing phenotype resembles those associated with deletions of SAGA complex components.
Sca7, the protein responsible, is a subunit of the hSAGA complex. Figure 2C ). Expression of expanded polyQ proteins was also associated with decreased activity from SAGA-regulated promoters (HIS4 and PHO5) but not from the SAGA-independent NCW2 promoter ( Figure 3A ). Similar to the results of expanded polyQ on SAGA function described by Hughes et al, 50 72Q reduced global acetylation of the SAGA-modified
histone H3 approximately to 60% of wild-type ( Figure 3B ). Global acetylation of the NuA4-modified histone H4 was reduced to a lesser extent, approximately 80% of wild-type ( Figure 3B ).
| Accumulation of misfolded polyQ proteins increases TRA1 expression
We previously observed that Tra1-bearing mutations in its PI3K domain (tra1 Q3 ) decrease nuclear localization of the protein. 64 We therefore assessed whether expressing polyQ expansion affects Tra1 localization using confocal microscopy. We found that expanded polyQ expression gene. 64 We assayed expression from the TRA1 promoter to evaluate whether expanded polyQ results in increased TRA1 expression.
As shown in Figure 4A , we found a~2.5-fold increase in TRA1 expression of a TRA1-promoter LacZ fusion upon expression of 72Q compared to the non-toxic 25Q. Increased transcription was also observed from promoters of other components of SAGA and NuA4, that is, NGG1, SPT7 and EAF1, as was the case for tra1 Q3
64
( Figure 5A ). We also observed that the polyQ-induced increase in 25Q 72Q 25Q 72Q +PolyQ Control FIGURE 3 PolyQ expansions reduce Tra1-regulated gene expression. A, Expression of GAL1-inducible 72Q induced a significant decrease in the expression from the SAGA-regulated genes HIS4 and PHO5. NCW2 is shown as a control. Gene expression was analyzed using LacZ transcriptional reporters and was assessed after overnight induction of polyQ in galactose under conditions that induced each promoter (absence of histidine or low phosphate, respectively). **P < 0.005, n = 3 ± SEM. B, Reduced histone acetylation in cells expression expanded polyQ. Immunoblot of total (H3 and H4) and acetylated histone H3 (H3-AcK14) and H4 (H4-AcK16) with or without expression of GAL1-inducible 25 and 72Q. *P < 0.05, **P < 0.005, n = 3 ± SEM the TORC1 (Target of Rapamycin Complex 1)-regulated signaling cascades that link nutrient availability to cell growth and division. In this screen, a tra1 mutant displayed a synthetic slow growth phenotype with a deletion of tor1. 51 Studies in mammalian cells report both a protective and adverse role for TORC1 in HD. 8, [67] [68] [69] [70] [71] We therefore tested the effect of modulating TORC1 activity on polyQ toxicity in yeast. First, we determined the effects of TORC1 inhibition using rapamycin ( Figure 6A ,B). We found that rapamycin treatment significantly reduced growth of cells expressing expanded 103Q protein in both solid and liquid media assays when compared to the untreated condition. Interestingly, rapamycin treatment did not significantly alter polyQ aggregation ( Figure 6C ). This result argues against a protective role for TORC1 inhibition by rapamycin through stimulating polyQ aggregates removal through autophagy. 68 Similar to rapamycin, a hyperactive allele of TOR1 (TOR1 L2134M ) 72 also exacerbated polyQ toxicity ( Figure 6D ,E). The TOR1 mutant had only a modest effect on the toxicity of TDP-43 ( Figure S4 ), a protein linked to amyotrophic lateral sclerosis, 73 indicating that the role of TORC1 may diverge in different diseases. TORC1 hyperactivation did not prevent the formation of polyQ aggregates ( Figure 6F ). These data indicate that precise regulation of TORC1 signaling is crucial for cells to cope with polyQ expansion. Interestingly, the same hyperactive TOR1 mutant decreases levels of glutathione, 74 which is important to counteract ROS accumulation in HD models. 75 TORC1 regulates translation and ribosome biogenesis in both yeast and mammals and decreased translation has been proposed as a contributor to polyQ toxicity in mammals. 20 Incidentally, cells expressing 72Q displayed increased sensitivity to the translational inhibitor cycloheximide ( Figure 7A,B) and decreased expression of ribosomal protein genes ( Figure 7C ) when compared to 25Q, further supporting a role for TORC1 signaling in polyQ toxicity. Therefore, we next investigated the role of downstream TORC1 effectors in polyQ toxicity. 59, 60, 78, 79 where it is degraded by the proteasome. 80 Here, we found that deleting SFP1, but not SCH9 exacerbated polyQ toxicity ( Figure 8A ). This agrees with Sfp1 and Sch9 having non-overlapping functions. 60 Indeed, the two deletion strains display specific phenotypes. Relevant to our study, sfp1Δ increases rapamycin sensitivity as compared to sch9Δ. mutant allele are viable with the mutations displaying epistasis, suggesting that both genes function in the same pathway ( Figure 8C ).
|
Indeed, tra1 Q3 displayed reduced ribosomal protein gene expression ( Figure 8D ). In the same way, nuclear depletion of Tra1 using the anchor-away approach decreases recruitment of Esa1 and Gcn5 to ribosomal protein gene promoters. 81 In agreement with reduction of ribosome protein gene levels, Sfp1-GFP relocalized to the cytoplasm upon 103Q expression, in contrast to its nuclear localization in cells expressing non-toxic 25Q
( Figure 9A ). Interestingly, cytoplasmic Sfp1 is recruited to polyQ aggregates ( Figure 9A ). To quantify recruitment or exclusion of Sfp1 in polyQ aggregates, we adapted a size-normalized, averaging-based analysis method developed by Li et al for studying Htt ex1 aggregates in mammalian cells. 82 Briefly, we analyzed several 1.75 × 1.75 μm polyQ aggregates containing regions of interest ( Figure 9B ). Then, we generated an intensity map by averaging multiple regions for 20 different cells ( Figure 9C ). We next calculated the fluorescent intensity of 103Q-RFP and Sfp1-GFP along a line across the region to generate an intensity curve for both channels. Similar shaped curves revealed incorporation of Sfp1-GFP into polyQ aggregates ( Figure 9D ). expression. Cells expressing a galactose-inducible version of α-synuclein-GFP were cultured in either glucose or galactose overnight and TRA1 expression was measured using a LacZ reporter. n = 3
inhibitor TSA ( Figure 11A ), indicating that deleting SFP1 may affect SAGA and possibly NuA4-mediated chromatin modifications that regulate PHO5 transcription. 83, 84 We next tested the effect of deleting SFP1 on the polyQ-induced upregulation of SAGA and NUA4 components observed in Figure 5A . While the transcription from the SPT7, NGG1 and EAF1 promoters was still increased upon expression of misfolded 72Q, SFP1 deletion abolished TRA1 upregulation ( Figure 11B ). These results suggest that Sfp1 is required for proper control of TRA1 expression upon polyQ expression. Sfp1 is a known TORC1 effector and TORC1 inhibition with rapamycin downregulates TRA1 expression 59 ( Figure 11C ), highlighting a role for TORC1 in the control of TRA1 transcriptional regu- Figure 11D ). Coupled to the observed decrease in TRA1 expression upon TORC1 inhibition by rapamycin ( Figure 11C ), our results establish that TORC1 signaling regulates TRA1 expression.
3 | DISCUSSION
| Tra1/SAGA and polyQ toxicity
The ability of cytoplasmic polyQ-expanded Htt ex1 to disrupt Tra1 functions echoes previous reports showing that expressing nuclear-targeted Htt ex1 results in transcriptional changes similar to deleting components of the SAGA complex. 50 Other reports show a similar phenotype using a different disease-associated polyQ protein, the SAGA-associated spinocerebellar ataxia 7 (SCA7). 44, 50 We do not detect significant nuclear localization of Htt ex1 in our model ( Figure 1 ). As Tra1 remains localized to the nucleus upon expression of expanded polyQ, it is unlikely that the two directly interact, thus favoring indirect regulation of Tra1 function by polyQ. Our previous genetic screen using a tra1 mutant allele revealed that Tra1 is linked to cellular responses of proteotoxic stress, such as the heat shock response, mitochondria homeostasis and TORC1
signaling. 51 Interestingly, all these processes are linked to polyQ toxicity. 8 were assessed by liquid growth assay in the presence (control) or absence (polyQ induced) of methionine ±0.1 μg/mL cycloheximide. The area under the curve was quantified for each replicates (n = 3), ***P < 0.001. C, PolyQ expression decreased expression of ribosomal protein genes. RNA was isolated from wild-type cells expressing GAL1-inducible 25Q or 72Q Htt ex1 -CFP after overnight induction in galactose-containing media and processed for RT-qPCR to assess transcript levels of RPL6, RPL30 and RPL38. *P < 0.05, **P < 0.01 (n = 3) genotoxic stress was regulated via TORC1 signaling through Sfp1. PolyQ expansions and expression of the tra1 Q3 mutant allele 64 are the only experimental conditions identified to date that increase TRA1 expression. Deletion of other SAGA/NuA4 components does not upregulate TRA1, indicating that disruption of HAT complexes cannot solely explain the phenotype. 64 Moreover, polyQ expansions also upregulated TRA1 in the absence of ADA2 ( Figure S5 ). Thus, an intact SAGA complex does not appear to be required for TRA1 upregulation by polyQ. Interestingly, polyQ-induced TRA1 expression requires Sfp1 (Figure 11 ). Microarray analyses revealed that overexpressing SFP1 does not upregulate TRA1, indicating that Sfp1 might regulate Tra1 indirectly. 60 Similar to what we observe with TRA1, deleting SFP1 abolishes upregulation of the proteasome regulator ADC17 during tunicamycin-induced endoplasmic reticulum stress. 85 Because in both cases, stress leads to Sfp1 relocalization to the cytoplasm, it appears that Sfp1 regulates these targets indirectly, potentially via its regulation of TORC1. In our case, relocalization of Sfp1 to the cytoplasm may disrupt the previously reported Sfp1 interaction 79 with Tra1 (which remains in the nucleus). Moreover, recruitment of Sfp1 to polyQ aggregates could contribute to reduced Sfp1 function and signaling in these cells, resulting in impaired Tra1/SAGA function.
Sfp1 is known for its ability to acquire a prion form termed 
106-109
The physiological relevance of the Tra1-Sfp1 interaction will require further investigation. A possible explanation for TRA1 transcriptional regulation by Sfp1/TORC1 is that TRA1 is regulated at connection observed in yeast.
| TORC1, SAGA and polyQ toxicity
Our data show that TORC1 has to be finely tuned for yeast cells to compensate for polyQ toxicity. This is not surprising considering the multitude of cellular processes regulated by TORC1. [116] [117] [118] Interestingly, both activation and inhibition of TORC1 are protective in rodent models of HD. 
| MATERIALS AND METHODS

| Yeast genetic manipulation and growth assays
All strains are derivatives of either BY4741/4742 or W303a (Table S1 ). Gene deletions were performed using standard yeast genetics procedures 124 and validated by sequencing. Plasmids were transformed using the lithium acetate method. 125 Cell growth was assessed by both spot assay on agar plates and growth in liquid culture as previously described. 126 Yeast cells were cultured overnight in selective synthetic complete media with 2% glucose as a sole carbon source. For spot assays, cultures were diluted to equal concentrations and then spotted in four 5-fold dilutions using a pinning tool with the most concentrated spot equalized at OD 600 0.2. Cells were grown on selective plates at 30 C for 2 days and imaged using a Geldoc system (Bio-Rad). For liquid culture, cells were diluted to OD 600 0.1 and incubated at 30 C. OD 600 was measured every 15 minutes using a BioscreenC plate reader (Growth curves USA) for 24 hours. Growth curves were generated and the area under the curve calculated for each biological replicates and a two-tailed Student's t-test was used to determine statistical significance between the different experimental conditions using Graphpad (Prism). To generate the sfp1Δ tra1 Q3 double mutant, the sfp1Δ and tra1 Q3 (CY6586) were mated and diploids were selected on media containing G418 and lacking leucine.
The diploid strain (CY8479) was sporulated in 3 mL 1% potassium acetate and tetrads were dissected. The haploid double sfp1 tra1 Q3 strain (CY8482) was selected based on its ability to grow on media containing G418 and media lacking leucine and histidine. 
| Drugs
| DNA constructs
Plasmids encoding fluorescently tagged Htt ex1 and LacZ reporter constructs carrying TRA1, PHO5 and NCW2 64,127 promoters in YCp87 128 were previously described (Table S2) . SPT7 promoter sequences relative to the translational start, −633 to +68, NGG1 promoter sequences −430 to +5 and EAF1 promoter sequences −890 to +31
were engineered by PCR as BamHI/HindIII fragments using 
Flag
. Blot was probed with anti-Flag. Anti-Pgk1 was used as loading control. Densitometric analysis from three independent samples is shown. B, Deletion of SFP1 has minimal effect on TRA1 mRNA levels. RNA was isolated from wild-type and sfp1Δ cells and processed for RT-qPCR to assess transcript levels of TRA1. C, Wild-type and sfp1Δ cells were spotted on YPD agar plates untreated, supplemented with 6 μg/mL calcofluor white (CFW), 5% ethanol (ETOH), 0.03% methyl methanesulfonate (MMS) or incubated at 39 C oligonucleotides listed in Table S3 and cloned into YCp87 128 to generate transcriptional reporters. Vectors encoding fluorescently tagged
Tra1 with yemRFP 129 were generated by replacing the eGFP coding sequence by the new codon-optimized fluorescent proteins using the BamHI/NotI sites in the previously described eGFP-Tra1 vector 130 using primers listed in Table S3 . 
(C) (D) FIGURE 11 Sfp1 and TORC1 regulate TRA1 expression in response to misfolded polyQ. A, Sfp1 regulates PHO5 expression. Cells expressing the PHO5-LacZ reporter were incubated in the absence of phosphate overnight and treated with trichostatin A (TSA) at the indicated concentration. Expression from the NCW2 promoter is shown as control. β-Galactosidase activity is shown as the average of three replicates with the SEM indicated by the error bars. ***P < 0.001 using a one-way ANOVA followed by a Tukey's multicomparison test. B, Deletion of SFP1 specifically abolishes TRA1 upregulation by polyQ. Gene expression from TRA1 and other SAGA (NGG1, SPT7) and NuA4 (EAF1) promoters after overnight induction of GAL1-inducible 72Q-CFP compared to 25Q-CFP in wild-type and sfp1Δ cells. Gene expression was analyzed using LacZ transcriptional reporters. **P < 0.005, ***P < 0.001, n = 3 ± SEM. C, Rapamycin treatment decreases transcription from the TRA1 promoter in both wild-type and sfp1Δ cells. Gene expression was analyzed using the TRA1-LacZ transcriptional reporter. ***P < 0.001, n = 3 ± SEM. D, Hyperactive TORC1 signaling prevents upregulation of TRA1 by polyQ. RNA was isolated from wild-type and TOR1 L2134M cells after overnight induction of GAL1-inducible 25 and 103Q Htt ex1 -CFP in galactose media and processed for RT-qPCR to assess transcript levels of TRA1. *P < 0.05
| Fluorescent microscopy
Cells were diluted 10× and transferred to LabTek imaging chambers (Thermo Inc.) and imaged at room temperature. Fluorescent microscopy was performed using a Zeiss 800 confocal microscope equipped with a 63× PlanAprochromoat objective (1.4 NA). Images were analyzed using the ImageJ software. 131 
| qRT-PCR
RNA extraction was performed using MasterPure Yeast RNA Purification Kit (Lucigen). cDNA synthesis was done by qScript Flex cDNA Synthesis Kit (Quanta Bioscience). The cDNA preparations were used as the template for amplification using PerfeCTa SYBR-Green Supermix (Quanta Bioscience). The primers used are listed in Table S3 . The relative expression level was calculated using the comparative Ct method and U3 was used as a reference gene.
| Western blot
Yeast cells were lysed using 0.1M NaOH for 5 minutes at room temperature, resuspended in SDS sample buffer and boiled for 5 minutes. 132 Proteins were separated using gel electrophoresis and transferred to polyvinylidene difluoride membrane. The membrane was blocked with 5% milk. Then the membrane was incubated with anti-Flag (M2; Sigma-Aldrich), anti-PGK1 (Invitrogen), anti-histone H3
and anti-histone H3K14 (Abcam) overnight, followed by 1-hour incubation with the appropriate fluorescent secondary antibody and imaged with an Odyssey infrared imager (Licor) to detect the signal.
| β-Galactosidase assay
Cells were harvested and resuspended in LacZ buffer. β-Galactosidase activity from 50 μL of cell lysate was calculated using o-nitrophenol-β-D-galactosidase as substrate and values were normalized to cell densities as previously described.
42,64
| Pull-down assay
Pull down was performed as previously described. 64 with calmodulin elution buffer. Finally, protein was mixed with SDS sample buffer and processed for gel electrophoresis followed by staining with coomassie blue and imaging with a Geldoc system (Bio-RAD).
| Statistical analysis
Unless indicated otherwise, a Student's t-test was used to determine statistical significance between the different experimental conditions using GraphPad Prism v6.0h. for the TOR1 mutant strain.
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